3-(2,2,2-trimethylhydrazine)propionate has been researched along with Acute Coronary Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cherniatina, MA; Kharchenko, AV; Mikhin, VP; Panchenko, GV; Tsukanova, IuA | 1 |
1 trial(s) available for 3-(2,2,2-trimethylhydrazine)propionate and Acute Coronary Syndrome
Article | Year |
---|---|
[Efficiency of meldonium in the complex therapy of acute coronary syndrome].
Topics: Acute Coronary Syndrome; Cardiovascular Agents; Coronary Angiography; Diastole; Drug Administration Routes; Drug Monitoring; Electrocardiography; Female; Humans; Male; Methylhydrazines; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Treatment Outcome; Ventricular Function, Left | 2014 |